semaglutide label FDA Warns on Certain Forms of Compounded and reduced OZEMPIC PEN 0.25MG (2MG/3ML), 3ML

In 2025, the European Medicines Agency concluded that NAION should be listed as a very rare side effect of semaglutide medications, including Ozempic, Wegovy, and Rybelsus, after reviewing clinical studies, adverse event reports, and post-market safety data

In a proteomic study on postmortem samples of PD patients it was shown that GSTP1-1 levels are increased in PD patients at advanced stages

A 2026 UK review of the acetylcholine mechanism, the ASCOMALVA Alzheimers trial and 2023 meta-analysis, the Ziegenfuss 2008 gym study, the reassuring 2025 dementia data and the unresolved stroke question versus Dihexas unproven HGF/c-Met synaptogenesis and the c-Met concern

In a registry maintained by the American Society for Metabolic and Bariatric Surgery 10 from June 2007 to May 2009, the most common bariatric procedure in the United States was Roux-en-Y gastric bypass, followed by sleeve gastrectomy